Literature DB >> 15471821

18F-FDG PET imaging in posttherapy monitoring of cervical cancers: from diagnosis to prognosis.

Tarik Z Belhocine1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471821

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  4 in total

1.  Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence.

Authors:  Sandro Sironi; Maria Picchio; Claudio Landoni; Stefania Galimberti; Mauro Signorelli; Valentino Bettinardi; Patrizia Perego; Costantino Mangioni; Cristina Messa; Ferruccio Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-16       Impact factor: 9.236

2.  Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Domeki; Yasushi Kaji; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2008-04-19       Impact factor: 5.315

Review 3.  Opportunities for 2-[(18)F] fluoro-2-deoxy-D-glucose PET/CT in cervical-vaginal neuroendocrine carcinoma: case series and literature review.

Authors:  Yin Lin; Wan Y Lin; Ji A Liang; Yu Y Lu; Hsin Y Wang; Shih C Tsai; Chia H Kao
Journal:  Korean J Radiol       Date:  2012-10-12       Impact factor: 3.500

4.  The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings.

Authors:  Hyun Hoon Chung; Won Jun Kang; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; June-Key Chung; Soon-Beom Kang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-08       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.